AIxCrypto Partners with BitMart to Launch Co-Branded Virtual Prepaid Cards for Web3 Users
- Partnered with BitMart to launch co-branded virtual prepaid cards, extending Web3 payments via a licensed operator.
- BitMart handles issuance and compliance; AIxC supplies community, marketing, product innovation, minimizing regulatory exposure.
- Launched Season 2, reports 1.64M wallets and 7,200 teams; prioritizes AI automation, developer tooling, institutional outreach.
Intro: AIxCrypto moves to bridge digital ecosystems with regulated payments
AIxCrypto Inc. (AIxC) announces a strategic partnership with crypto exchange BitMart to launch a co-branded virtual prepaid card program for eligible users in the AIxC ecosystem. The tie-up positions AIxC to extend Web3 utility into everyday payment channels while keeping regulated financial operations with a licensed partner. Company leadership frames the initiative as a practical step toward real-world use cases for blockchain-native communities.
BitMart to operate issuance, AIxC to drive demand
Under the arrangement, BitMart acts as the exclusive operator, handling card issuance, user onboarding, compliance oversight, customer support and all payment infrastructure subject to regional and regulatory requirements. AIxC supplies community reach, brand participation and marketing support, creating a clear operational split that leaves regulated payments and custody to licensed entities. The structure aims to reduce regulatory exposure for AIxC while enabling a scalable payments experience for its user base.
Strategic aim: real-world utility without becoming a regulated financial provider
AIxC frames the program as part of a broader push for compliant payment rails that convert on-chain engagement into off-chain purchasing power. By outsourcing regulated functions to BitMart, AIxC concentrates on product innovation, community growth and integration of AI-driven features across its ecosystem. The company signals this model as a template for future collaborations where it supplies developer tooling, user experience and distribution while licensed partners handle financial regulation and settlement.
Seasonal gaming, platform growth and features
Separately, AIxC completes Season 1 of AIxC Hub’s competitive S1 Arena and launches Season 2, transforming the Hub into a Web2-to-Web3 gateway powered by AI Agent infrastructure and integrated with the EAI‑RWA ecosystem. Season-based simulations, leaderboards and per-season settlements now evolve into new features such as Tenki Stargaze and Fortune Collection. AIxC reports more than 1.64 million registered wallet addresses and over 7,200 registered teams.
Institutional outreach and developer engagement
AIxC co-hosts a panel at ConsensusHK titled “Beyond Scaling: AIxC and the Era of Autonomous DeFi,” reinforcing engagement with institutions and developers. The company states its roadmap prioritizes AI-driven automation, developer tooling and institutional outreach, and it plans to convert conference momentum into partnerships, platform integrations and measurable user onboarding over coming quarters.
Related Cashu News

CRISPR Therapeutics AG Achieves Financial Progress Amid Advancements in Gene-Editing Portfolio
CRISPR Therapeutics AG (Ticker: UNDEFINED) showcases a pivotal moment in its financial journey with the release of its results for the first quarter of 2026. Highlighting a revenue of $1.46 million, t…

MetaVia to Present Innovative Cardiometabolic Research at 2026 ADA Scientific Sessions
MetaVia is set to showcase its innovative research in cardiometabolic diseases at the upcoming American Diabetes Association (ADA) Scientific Sessions in 2026, following the acceptance of three late-b…

Ionis Pharmaceuticals Advances TRYNGOLZA for Hypertriglyceridemia and Diranersen for Alzheimer's Disease
Ionis Pharmaceuticals has made headlines in the biotechnology sector with the promising potential of its drug TRYNGOLZA, which is designed to treat severe hypertriglyceridemia. During a recent healthc…

ImmunityBio Partners with BCG Laboratory to Enhance Bladder Cancer Treatment Supply and Options
ImmunityBio has secured a critical partnership with Japan's BCG Laboratory to enhance the supply of Bacillus Calmette-Guérin (BCG) in the United States, addressing an urgent need in the treatment of b…